Clinical Research Division investigators Clurman, Kiem elected to ASCI

Clinical Research Division investigators Drs. Bruce Clurman and Hans-Peter Kiem have been elected as members of the American Society for Clinical Investigation (ASCI), a national medical honor society. Their induction took place at a reception for new members during a meeting of the society last month in Chicago.

Clurman has made key discoveries that shed light on how defects in the cell-division cycle can lead to cancer. His work may lead to the development of new diagnostic tests and treatments for a variety of cancers.

Kiem has advanced the field of gene therapy as a potential treatment for cancer and genetic diseases such as Fanconi anemia. His work has focused on developing improved methods for transferring therapeutic genes into blood-forming (hematopoietic) stem cells.

The ASCI comprises more than 2,700 physician-scientists from all medical specialties, who were elected to the society because of their outstanding records of scholarly achievement in biomedical research. The society considers the nominations of several hundred physician-scientists from the United States and abroad each year and elects up to 80 new members each year. Members must be 45 years of age or younger when elected, reflecting accomplishments by researchers relatively early in their careers.